Archives

Use the basic search or click on advanced for more search options.

Advanced Search Basic Search Advanced Search

Publications

Section

Select publication to see the relevant sections.

Publication Date

    E.g., 2018-10-23
    E.g., 2018-10-23

Archive Search

2 results
12:00 AM, Aug 15, 2016  |  BioCentury | Finance

Serving returns

III Sorrento Therapeutics Inc. (NASDAQ:SRNE) Four biosimilar mAbs for cancer and autoimmune indications licensed from Mabtech
12:00 AM, Aug 22, 2005  |  BioCentury | Emerging Company Profile

Corporate Profile

Corporate partners: NA Employees: 24 Funds raised: £10 million ($18.6 million) Investors: Prelude Ventures; Quester; Mabtech